Search
Feed aggregator
GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial
In the largest study of its kind, GSK’s two-drug regimen Dovato demonstrated non-inferior efficacy compared to Gilead Sciences’ three-drug regimen Biktarvy for the treatment of HIV-1.
2024 Job Search Toolkit
BioSpace has updated our Job Search Toolkit, including recent resources to help you succeed with your next job search.
World Pharma News
- AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors
- Researchers identify natural compound that disarms drug-resistant bacteria
- Scientists discover a new way to make drug-resistant cancer treatable again
- A new drug concept to treat obesity and type 2 diabetes
- Autonomous AI-based drug prescribing rife with potential problems